196 related articles for article (PubMed ID: 33970608)
1. Encounters between Cas9/dCas9 and G-Quadruplexes: Implications for Transcription Regulation and Cas9-Mediated DNA Cleavage.
Hoque ME; Mustafa G; Basu S; Balci H
ACS Synth Biol; 2021 May; 10(5):972-978. PubMed ID: 33970608
[TBL] [Abstract][Full Text] [Related]
2. Targeting G-quadruplex Forming Sequences with Cas9.
Balci H; Globyte V; Joo C
ACS Chem Biol; 2021 Apr; 16(4):596-603. PubMed ID: 33769784
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.
Koopal B; Kruis AJ; Claassens NJ; Nobrega FL; van der Oost J
ACS Synth Biol; 2019 Feb; 8(2):216-222. PubMed ID: 30668910
[TBL] [Abstract][Full Text] [Related]
4. Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.
Wu H; Wang F; Jiang JH
Chembiochem; 2021 Jun; 22(11):1894-1900. PubMed ID: 33433941
[TBL] [Abstract][Full Text] [Related]
5. Effective Blocking of Microbial Transcriptional Initiation by dCas9-NG-Mediated CRISPR Interference.
Kim B; Kim HJ; Lee SJ
J Microbiol Biotechnol; 2020 Dec; 30(12):1919-1926. PubMed ID: 32958732
[TBL] [Abstract][Full Text] [Related]
6. G-Quadruplex-Enabling Sequence within the Human Tyrosine Hydroxylase Promoter Differentially Regulates Transcription.
Farhath MM; Thompson M; Ray S; Sewell A; Balci H; Basu S
Biochemistry; 2015 Sep; 54(36):5533-45. PubMed ID: 26284527
[TBL] [Abstract][Full Text] [Related]
7. Stalling of Transcription by Putative G-quadruplex Sequences and CRISPR-dCas9.
Hoque ME; Kabir ML; Shiekh S; Balci H; Basu S
bioRxiv; 2024 Mar; ():. PubMed ID: 38559215
[TBL] [Abstract][Full Text] [Related]
8. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
Biotechnol Bioeng; 2016 Dec; 113(12):2739-2743. PubMed ID: 27240718
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation.
Cai R; Lv R; Shi X; Yang G; Jin J
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834313
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
12. An engineered ScCas9 with broad PAM range and high specificity and activity.
Chatterjee P; Jakimo N; Lee J; Amrani N; Rodríguez T; Koseki SRT; Tysinger E; Qing R; Hao S; Sontheimer EJ; Jacobson J
Nat Biotechnol; 2020 Oct; 38(10):1154-1158. PubMed ID: 32393822
[TBL] [Abstract][Full Text] [Related]
13. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
[TBL] [Abstract][Full Text] [Related]
14. CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway.
Xu S; Kim J; Tang Q; Chen Q; Liu J; Xu Y; Fu X
Protein Cell; 2020 May; 11(5):352-365. PubMed ID: 32170574
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in
Yu S; Price MA; Wang Y; Liu Y; Guo Y; Ni X; Rosser SJ; Bi C; Wang M
ACS Synth Biol; 2020 Jul; 9(7):1781-1789. PubMed ID: 32551562
[TBL] [Abstract][Full Text] [Related]
18. FokI-dCas9 mediates high-fidelity genome editing in pigs.
Fisicaro N; Salvaris EJ; Philip GK; Wakefield MJ; Nottle MB; Hawthorne WJ; Cowan PJ
Xenotransplantation; 2020 Jan; 27(1):e12551. PubMed ID: 31407391
[TBL] [Abstract][Full Text] [Related]
19. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
20. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
